Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
Oncopeptides
OM:ONCO Community
1
Narratives
written by author
1
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
Oncopeptides
Popular
Undervalued
Overvalued
Oncopeptides
DA
DailyInvestors
Community Contributor
Oncolytics Biotech: A Beacon of Hope in Cancer Treatment
Oncolytics Biotech: A Beacon of Hope in Cancer Treatment In the ever-evolving landscape of oncology, Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) is emerging as a company demonstrating significant promise.
View narrative
SEK 2.56
FV
40.5% undervalued
intrinsic discount
47.64%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
10 days ago
author updated this narrative
Your Valuation for
ONCO
Oncopeptides
Your Fair Value
SEK
Current Price
SEK 1.52
65.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-2b
346m
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 346.3m
Earnings SEK 68.5m
Advanced
Set as Fair Value